American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.
about
Cytomegalovirus infection in transplant recipientsEpstein-Barr virus infection and posttransplant lymphoproliferative disorderFlow cytometry and solid organ transplantation: a perfect matchRisk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control studyCurrent characteristics and outcome of cytomegalovirus infections after kidney transplantation.Variable viral clearance despite adequate ganciclovir plasma levels during valganciclovir treatment for cytomegalovirus disease in D+/R- transplant recipients.Prospective, comprehensive, and effective viral monitoring in Cuban children undergoing solid organ transplantation.Reactivation of multiple viruses in patients with sepsis.Efficacy and safety of a lower-dose valganciclovir (valcyte) regimen for cytomegalovirus prophylaxis in kidney and pancreas transplant recipients.Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.What's new in clinical solid organ transplantation by 2013.Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxisHeteromerization of human cytomegalovirus encoded chemokine receptors.Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipientsPost-transplant lymphoproliferative disorder: case report and review of susceptibility to EBV in the Scottish adult renal transplant pool.Homozygosity for the toll-like receptor 2 R753Q single-nucleotide polymorphism is a risk factor for cytomegalovirus disease after liver transplantation.Infections after lung transplantation: time of occurrence, sites, and microbiologic etiologies.Performance of two commercially available automated immunoassays for the determination of Epstein-Barr virus serological status.Ventricular assist devices as bridge to heart transplantation: impact on post-transplant infections.Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response.Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral CenterCorrelation and clinical utility of pp65 antigenemia and quantitative polymerase chain reaction assays for detection of cytomegalovirus in pediatric renal transplant patients.Preformed frequencies of cytomegalovirus (CMV)-specific memory T and B cells identify protected CMV-sensitized individuals among seronegative kidney transplant recipients.Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases.Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?Immune surveillance and lymphoid malignancy in immunocompromised host.Quinolone prophylaxis for the prevention of BK virus infection in kidney transplantation: study protocol for a randomized controlled trial.Efficacy of rabbit anti-thymocyte globulin for steroid-resistant acute rejection after liver transplantation.Immunobiology of human cytomegalovirus: from bench to bedside.Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infectionLaboratory assays for Epstein-Barr virus-related disease.Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipientsThe risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral controlChoice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients.Cytomegalovirus infections in solid organ transplantation: a review.Cytomegalovirus immunoglobulin decreases the risk of cytomegalovirus infection but not disease after pediatric lung transplantation.Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantationElevated CXCL10 (IP-10) in bronchoalveolar lavage fluid is associated with acute cellular rejection after human lung transplantation.
P2860
Q26801802-DCD312C9-6B8D-40EE-93A9-AF1477EC3CD0Q27024229-07167D15-5733-414B-B4C9-B817180A02FFQ27026499-EFB32075-1B34-4DC9-B1C3-A37E249C6D2FQ28298477-94B5668B-B1A8-40A1-A947-049C5BFB497CQ33416126-E9A3C28F-7F4E-4764-BA65-69A4554F8785Q33522300-6E4D5893-FECC-49A0-84D2-F90865DA2845Q33671565-B8C06B0C-BB29-4169-BFCC-2A956FFC26BCQ33740315-EBBE978D-A4B7-4D5B-AC3C-399F14368803Q34432814-D047C232-267D-4482-8BE8-E929710ECFC7Q34455315-80F97E43-C51A-4A2C-9051-56EAA7ABBE3BQ34761349-1AB01AC0-D8EB-4C9C-AE79-88088F201386Q35051236-C3DE223B-4570-43A1-8BA7-41428F0A2E15Q35140692-2941EF04-70D9-426F-ACF3-A99A92CE3EEFQ35167034-DD59E03B-8B4E-484C-83A8-4B4E6621CE9BQ35544428-18380A18-CA36-4A78-9798-32E93D543F2FQ35574186-A166289D-609C-4E8F-A546-36A0F61309D4Q35694674-CD1E5884-B683-4A1C-B31E-A091C9067274Q35834958-4A5063A6-DCB3-4DE1-8176-BDF6253E0D9BQ36017708-7AC342DF-CE1E-4947-9B46-D76E502BCDC9Q36071675-B3970C94-ED60-490F-A7DB-441B808BAF58Q36099296-993FDD96-F69A-4006-8811-177162EFCD23Q36194638-4AB41D56-415F-4EAF-9EE3-8CC69F170D61Q36288594-DAB02F05-F2AB-4CA5-A751-378D90304BC5Q36293963-AD4F324C-22EC-4B03-A4B2-B454B860CC13Q36747670-D3958435-6DA8-42BC-B20C-5671E36A2A85Q36752124-13E4D47E-B959-4475-ACF4-2CA4B0DEE6A0Q36831205-DA881DEC-66E2-4343-BB16-5EDF3E97D4EBQ36952467-CD28AF99-F8B6-46EA-B2B9-2BA407389CB1Q37003621-208F8A90-4617-4841-BE15-3BCACD73C617Q37050965-BAE59C8F-77F7-4598-A471-7215890411ABQ37157642-5FB0E47E-E0BE-4433-AD92-44CD827FAFABQ37192117-B5457C9D-36CD-4643-9A18-4ACFA5995A5BQ37272283-5BD9AF44-ADFC-46A3-93DD-3C0562256A00Q37304893-067FE9BE-CB0E-4491-8013-F7B3A58E8DE1Q37308147-DAF126A9-022F-44DA-A78C-77B8EB1F36F8Q37318303-9C84A939-F196-4923-A1BF-397C1E33761AQ37359332-1BB0F3B0-6EEA-4B41-8095-B259E0D56708Q37407845-F6C337A9-693E-45BC-BA35-8BC61EAED1EEQ37408216-5ADE2F2E-4A5C-4E50-AE28-EDE21E91B97EQ37423352-E54BB860-DCE0-4214-ABF9-444E281F9557
P2860
American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
American Society of Transplant ...... ents of organ transplantation.
@en
American Society of Transplant ...... ents of organ transplantation.
@nl
type
label
American Society of Transplant ...... ents of organ transplantation.
@en
American Society of Transplant ...... ents of organ transplantation.
@nl
prefLabel
American Society of Transplant ...... ents of organ transplantation.
@en
American Society of Transplant ...... ents of organ transplantation.
@nl
P2093
P2860
P1476
American Society of Transplant ...... ents of organ transplantation.
@en
P2093
AST ID Working Group on Infectious Disease Monitoring
M Michaels
P2860
P304
P356
10.1111/J.1600-6143.2005.01207.X
P407
P577
2006-02-01T00:00:00Z